Navigation Links
Esbriet® (pirfenidone) Benefit Granted by German Federal Joint Committee (G-BA)
Date:3/15/2012

rticipate in the conference call by dialing 800-891-8257 (U.S.) or +1-212-271-4651 (international), conference ID# 21582928.  A replay of the webcast and teleconference will be available approximately three hours after the call.

To access the webcast, please log on to the company's website at www.intermune.com at least 15 minutes prior to the start of the call to ensure adequate time for any software downloads that may be required.

A telephonic replay will be available for 10 business days following the call and can be accessed by dialing 800-633-8284 (U.S.) or +1 402-977-9140 (international), and entering the conference ID# 21582928.

About Esbriet®

Esbriet® (pirfenidone) is an orally active drug, indicated in adults for the treatment of mild-to-moderate idiopathic pulmonary fibrosis (IPF).  The anti-fibrotic acting pirfenidone inhibits the synthesis of TGF-beta, a chemical mediator that controls many cell functions including proliferation and differentiation, and plays a key role in fibrosis.  It also inhibits the synthesis of TNF-alpha, a cytokine that is known to have an active role in inflammation.

On February 28, 2011, the European Commission (EC) granted marketing authorization for Esbriet® in adults for the treatment of mild to moderate IPF.  The approval authorizes marketing of Esbriet® in all 27 EU member states.  Esbriet® has since been approved for marketing in Norway and Iceland.  In addition to Germany, Esbriet® is commercially available in Austria, Norway, Denmark and Luxembourg.

Since 2008, pirfenidone has been marketed in Japan as Pirespa® by Shionogi & Co. Ltd.  In the United States, pirfenidone is currently being evaluated for the treatment of IPF in another clinical trial and is not yet approved by the FDA for this indication.

About IPF

Idiopathic pulmonary fibrosis
'/>"/>

SOURCE InterMune, Inc.
Copyright©2010 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6

Related medicine technology :

1. InterMune Reports Preliminary Fourth Quarter 2011 Esbriet® (pirfenidone) Revenue and Other Recent Business Highlights
2. New Data Demonstrate Longer-Term Safety Profile of Esbriet®
3. InterMune Announces Launch of Esbriet® (pirfenidone) in Germany
4. InterMune Receives European Union Approval for Esbriet® (pirfenidone)
5. FDA Advisory Committee Recommends Approval of InterMunes Esbriet(R) (pirfenidone) for Idiopathic Pulmonary Fibrosis
6. New England Journal of Medicine Article Reviews the Benefits of Ingenol Mebutate in Field Treatment of Actinic Keratoses
7. Data in NEJM shows Novartis drug Signifor® is first therapy to provide rapid, durable benefit for Cushings disease patients in Phase III study
8. Thera Max® Cold and Flu Brand Receives Great Benefits from Its Ongoing Social Media Marketing Awareness Program
9. Sleep Breathing Machine Shows Clear Benefits in Children with Sleep Apnea
10. Study Highlights CyberKnife SBRT Benefits for Treatment of Central Lung Tumors
11. Recent Study Reveals Benefits to Women From DHEA Hormone
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/17/2013)... 2013  Sorrento Therapeutics, Inc. (OTCBB: SRNE; or ... Small Business Technology Transfer Research (STTR) grant (#1R42AI098182-02) ... Diseases (NIAID), a division of the National Institutes ... human antibody therapeutics to combat Staphylococcus aureus ... including methicillin-resistant S. aureus (MRSA), was ...
(Date:5/17/2013)... 17, 2013  Sony Biotechnology Inc. ("Sony") today announced the ... and 130um sorting chip.  Sony will also be exhibiting its ... SH800 Cell Sorter, the EC800 flow cytometer, and new SP6800 ... 2013, which will be held at the San ... California , from May 20 - 22.  ...
(Date:5/17/2013)... , May 17, 2013  TechAtlas Group ... for their competitive landscape map for the Chronic ... over 90 international companies with drugs and devices ... CKD and its sequelae. (Logo:  ... , hypertension - renal denervation ...
Breaking Medicine Technology:Sorrento Therapeutics, Inc. announces its approach to developing human antibody therapeutics against MRSA receives continued support from the National Institute of Allergy and Infectious Diseases 2Sorrento Therapeutics, Inc. announces its approach to developing human antibody therapeutics against MRSA receives continued support from the National Institute of Allergy and Infectious Diseases 3Sorrento Therapeutics, Inc. announces its approach to developing human antibody therapeutics against MRSA receives continued support from the National Institute of Allergy and Infectious Diseases 4Sony Delivers New Technology for Science to CYTO 2013 2TechAtlas Group Releases Innovative Chronic Kidney Disease Landscape Map 2
... Call to discuss the company,s third quarter financial ... 11:00 a.m. EDT (8:00 a.m. PDT). SUNNYVALE, Calif., ... PCYC ) today announced that it has entered ... leading French independent pharmaceutical company. The alliance will ...
... TLR8 Agonist to Advance for Treatment of AllergySAN DIEGO ... biopharmaceutical company focused on the development of novel Toll-Like ... respiratory and inflammatory diseases, announced today that it has ... selective intranasal TLR8 agonist for the treatment of allergic ...
Cached Medicine Technology:Pharmacyclics announces Global Strategic Alliance with Les Laboratoires Servier 2Pharmacyclics announces Global Strategic Alliance with Les Laboratoires Servier 3Pharmacyclics announces Global Strategic Alliance with Les Laboratoires Servier 4Pharmacyclics announces Global Strategic Alliance with Les Laboratoires Servier 5VentiRx Pharmaceuticals Initiates Phase I Clinical Trial of VTX-1463, a Novel TLR8 Agonist for the Treatment of Allergic Rhinitis 2
(Date:5/18/2013)... May 18, 2013 Show And Go Training, ... various different training systems that is all about is getting ... the attention of http://ShowAndGoTrainingReview.com ’s Stan Stevenson, prompting ... is a unique “four phase system” designed to make you ... of time spent working out in the gym. The training ...
(Date:5/18/2013)... Angeles, Ca (PRWEB) May 18, 2013 Losing ... of people. But among the horde of new weight loss ... one most talked about. Recent studies about this newest weight ... achieve one’s ideal body shape. , Garcinia Cambogia is a ... like a tamarind. Eating the fruit can suppress a person’s ...
(Date:5/18/2013)... 18, 2013 John Ravera, D.D.S., a ... of a new member to his dental team, Courtney Marino. ... the field for over 10 years. She received her degree ... was elected a member of Sigma Pi Alpha, a national ... enjoys working with patients of all ages, helping them understand ...
(Date:5/18/2013)... Provo, UT (PRWEB) May 18, 2013 Medical ... pre-launch orders for its much anticipated mobility aid with its ... to create a hands-free crutch alternative that injured ... a broken ankle, for example, can remain active and walk ... team is using its reservation system to ensure those who ...
(Date:5/17/2013)... Salt Lake City, Utah (PRWEB) May 17, 2013 ... muscle by providing their corporate wellness programs to ... system. This has been achieved through rigorous ... into a greater capacity for employee interactions via ... specializes in helping businesses lower employee healthcare ...
Breaking Medicine News(10 mins):Health News:Show And Go Training: Review Examining Eric Cressy's Workout Program Revealed 2Health News:Lose Weight Without Dieting or Exercising with Garcinia Cambogia Select Now Available At HealthCareSupplementz.com 2Health News:Newport Beach Cosmetic Dentist John Ravera Adds New Member to Dental Team 2Health News:FlexLeg Begins Offering New Mobility Aid 2Health News:New Telecommunications Upgrade Provides More Capacity for National Corporate Wellness Programs offered by Orriant 2
... Wellness Festival with ... at 10 a.m., BOSTON, May 31 Cyndi Lauper, in ... from her rehearsal,on Friday night to meet with some of this ... http://www.newscom.com/cgi-bin/prnh/20080531/CLSA004 ), The 23rd Annual AIDS Walk Boston ...
... SAN CLEMENTE, Calif., May 30 Hero Nutritionals,introduced Slice ... adults, at,the Natural Products Expo West in March 2008. ... Coenzyme Q10. Though CoQ10 is found in every cell ... from the word,ubiquitous for ,found everywhere, low levels of ...
... World Report has ranked,Cincinnati Children,s Hospital Medical Center the ... pediatrics in the 2008 edition of,its annual "America,s Best ... has ever received from U.S. News., "This is ... debt of thanks,to the thousands of employees who helped ...
... 30 The National Alliance on,Mental Illness (NAMI) ... to public education about mental illness at NAMI,s ... NAMI executive director Mike Fitzpatrick made the announcement ... which he discussed the premiere of,two television documentaries ...
... BOSTON, May 30 The following is being issued,by the ... 1,200 physician scientists from 58 countries across the globe, ... When: Wednesday, June 4-Monday, June 9, Where: Boston ... To accelerate science that improves patient care, Wednesday, June ...
... Deadline is Dec. 31, but FDA urges asthma patients ... 30 (HealthDay News) -- Asthma inhalers that contain the ... that harm the ozone layer. And these inhalers won,t ... are urging patients to switch to alternative inhalers now. ...
Cached Medicine News:Health News:Sunday's AIDS Walk Boston at the Esplanade Gets Tribute from Cyndi Lauper at True Colors Concert Tour Launch Rehearsal 2Health News:U.S. News Ranks Cincinnati Children's Among Top Three U.S. Children's Hospitals 2Health News:U.S. News Ranks Cincinnati Children's Among Top Three U.S. Children's Hospitals 3Health News:NAMI Blog: PBS, MTV and Jane Pauley 2Health News:World-Renowned Scientists to Lead Immunology Course 2Health News:World-Renowned Scientists to Lead Immunology Course 3Health News:World-Renowned Scientists to Lead Immunology Course 4Health News:Ozone-Depleting Inhalers Being Phased Out 2Health News:Ozone-Depleting Inhalers Being Phased Out 3
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
Medicine Products: